指南与共识支持与姑息治疗头颈与中枢神经肿瘤

儿童、青少年及年轻成人癌症生存者耳毒性监测建议:国际儿童癌症晚期效应指南协调组与PanCare联盟合作报告

Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium.
指南 / 共识 · Lancet Oncol · 2019-01-01

儿童、青少年及年轻成人(CAYA)癌症生存者接受铂类药物、头或脑放疗或两者后耳毒性风险增加。国际指南协调组组织来自十国的32名专家组成多学科专家组,评估铂类化疗和头或脑放疗后耳毒性的证据质量,并制定和协调CAYA癌症生存者的耳毒性监测建议。

要点

  • 接受铂类药物、头或脑放疗或两者的CAYA癌症生存者耳毒性(听力损失、耳鸣或两者)风险增加。
  • 听力损失定义、监测方式建议和补救措施的差异阻碍了耳毒性监测在临床环境中的实施。
  • 国际指南协调组组织来自十国的32名专家组成多学科专家组,评估证据质量并制定和协调耳毒性监测建议。

核心结论

  • 国际指南协调组组织多学科专家组制定并协调了CAYA癌症生存者耳毒性监测建议。

研究设计与样本

  • 国际指南协调组组织国际多学科专家组,包括来自十国的32名专家,评估铂类化疗和头或脑放疗后耳毒性的证据质量,并制定和协调监测建议。

主要发现

  • 接受铂类药物、头或脑放疗或两者的CAYA癌症生存者耳毒性(听力损失、耳鸣或两者)风险增加。
  • 听力损失定义、监测方式建议和补救措施的差异阻碍了耳毒性监测在临床环境中的实施。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Childhood, adolescent, and young adult (CAYA) cancer survivors treated with platinum-based drugs, head or brain radiotherapy, or both have an increased risk of ototoxicity (hearing loss, tinnitus, or both). To ensure optimal care and reduce consequent problems-such as speech and language, social-emotional development, and learning difficulties-for these CAYA cancer survivors, clinical practice guidelines for monitoring ototoxicity are essential. The implementation of surveillance across clinical settings is hindered by differences in definitions of hearing loss, recommendations for surveillance modalities, and remediation. To address these deficiencies, the International Guideline Harmonization Group organised an international multidisciplinary panel, including 32 experts from ten countries, to evaluate the quality of evidence for ototoxicity following platinum-based chemotherapy and head or brain radiotherapy, and formulate and harmonise ototoxicity surveillance recommendations for CAYA cancer survivors.

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. Clemens E, van den Heuvel-Eibrink MM, Mulder RL, et al. Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium. Lancet Oncol. 2019. PMID: 30614474. doi:10.1016/S1470-2045(18)30858-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。